Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
65.49
+3.55 (5.73%)
May 22, 2026, 4:00 PM EDT - Market closed

Haemonetics Balance Sheet

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Apr '23 Apr '22
Cash & Equivalents
245.44306.76178.8284.47259.5
Cash & Short-Term Investments
245.44306.76178.8284.47259.5
Cash Growth
-19.99%71.57%-37.15%9.62%34.94%
Accounts Receivable
216.86202.66206.56179.14159.38
Inventory
306.37365.14317.2259.38293.03
Other Current Assets
66.2160.4166.3446.7444.13
Total Current Assets
834.88934.98768.9769.72756.03
Net Property, Plant & Equipment
305.76284.05311.36310.89258.48
Other Intangible Assets
447.66455.74406.12275.77310.26
Goodwill
656.37604.27565.08466.23467.29
Other Long-Term Assets
151.26171.91144.13112.2267.67
Total Assets
2,3962,4512,1961,9351,860
Accounts Payable
51.066773.3663.9358.37
Accrued Expenses
68.1959.4280.7164.4848.54
Short-Term Debt
5.02303.5610.2311.78214.15
Other Current Liabilities
158.34148.13136.09111.63121.21
Total Current Liabilities
282.6578.11300.38251.82442.27
Long-Term Debt
1,220921.23797.56754.1559.44
Other Long-Term Liabilities
97.44130.77137.69110.91108.6
Total Long-Term Liabilities
1,3171,052935.25865.01668.04
Total Liabilities
1,6001,6301,2361,1171,110
Common Stock
0.450.480.510.50.51
Additional Paid-in Capital
554.14523.26634.63594.71572.48
Accumulated Other Comprehensive Income
-37.61-55.08-35.63-30.38-25.95
Retained Earnings
279.34352.17360.46253.17202.39
Shareholders' Equity
796.32820.84959.96818749.42
Total Liabilities & Equity
2,3962,4512,1961,9351,860
Total Debt
1,2251,225807.79765.89773.59
Net Cash (Debt)
-979.14-918.03-628.99-481.42-514.09
Net Cash Per Share
-20.68-18.10-12.24-9.36-10.01
Book Value
796.32820.84959.96818749.42
Book Value Per Share
16.8216.1818.6815.9114.59
Tangible Book Value
-307.7-239.18-11.2476-28.12
Tangible Book Value Per Share
-6.50-4.71-0.221.48-0.55
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q